SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-015223
Filing Date
2018-08-10
Accepted
2018-08-10 16:06:16
Documents
48
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20180630_10q.htm 10-Q 620148
2 EXHIBIT 31.1 ex_120359.htm EX-31.1 10413
3 EXHIBIT 31.2 ex_120360.htm EX-31.2 10646
4 EXHIBIT 32.1 ex_120361.htm EX-32.1 5380
5 EXHIBIT 32.2 ex_120362.htm EX-32.2 5858
  Complete submission text file 0001437749-18-015223.txt   3554496

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dffn-20180630.xml EX-101.INS 680253
7 XBRL TAXONOMY EXTENSION SCHEMA dffn-20180630.xsd EX-101.SCH 38678
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20180630_cal.xml EX-101.CAL 29859
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20180630_def.xml EX-101.DEF 271345
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20180630_lab.xml EX-101.LAB 247994
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20180630_pre.xml EX-101.PRE 287936
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 181008890
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1